These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30180746)

  • 21. [New aspects in the prevention and therapy of cytostatic drug-induced nausea and vomiting].
    Evers C; Riess H
    Z Arztl Fortbild (Jena); 1992 Sep; 86(17):847-53. PubMed ID: 1413901
    [No Abstract]   [Full Text] [Related]  

  • 22. In search of the ideal antiemetic.
    Seegenschmiedt MH
    Acta Oncol; 2004 Sep; 43 Suppl 15():13-8. PubMed ID: 15370625
    [No Abstract]   [Full Text] [Related]  

  • 23. Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy.
    Italian Group for Antiemetic Research
    N Engl J Med; 2000 May; 342(21):1554-9. PubMed ID: 10824073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal selection of antiemetics in children receiving cancer chemotherapy.
    Roila F; Aapro M; Stewart A
    Support Care Cancer; 1998 May; 6(3):215-20. PubMed ID: 9629872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug treatment of chemotherapy-induced delayed emesis.
    Tavorath R; Hesketh PJ
    Drugs; 1996 Nov; 52(5):639-48. PubMed ID: 9118814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of simple, easy-to-follow antiemetic guidelines.
    Feyer P
    Acta Oncol; 2004 Sep; 43 Suppl 15():5-8. PubMed ID: 15370623
    [No Abstract]   [Full Text] [Related]  

  • 27. A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study.
    Navari RM; Einhorn LH; Loehrer PJ; Passik SD; Vinson J; McClean J; Chowhan N; Hanna NH; Johnson CS
    Support Care Cancer; 2007 Nov; 15(11):1285. PubMed ID: 17375339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Perceptual gap between oncologists/oncology nurses and patients in the management and impact of chemotherapy/radiotherapy-induced nausea and vomiting: French results of the GAP survey].
    Morin S; Leurs I; Bousquet MN; Scotté F
    Bull Cancer; 2016 May; 103(5):469-77. PubMed ID: 27015797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Single-dose First-generation 5-HT
    Kaito D; Iihara H; Funaguchi N; Endo J; Ito F; Yanase K; Toyoshi S; Sasaki Y; Hirose C; Arai N; Kitahora M; Ohno Y; Itoh Y; Minatoguchi S
    Anticancer Res; 2017 Apr; 37(4):1965-1970. PubMed ID: 28373467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-HT3 receptor antagonists in the control of cisplatin-induced delayed emesis.
    Ossi M; Anderson E; Freeman A
    Oncology; 1996 Jun; 53 Suppl 1():78-85. PubMed ID: 8692556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of emesis in cancer patients].
    Slimane K; Perez A; Ruffié P; di Palma M
    Bull Cancer; 2004 May; 91(5):403-8. PubMed ID: 15281279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olanzapine for nausea and vomiting.
    Licup N
    Am J Hosp Palliat Care; 2010 Sep; 27(6):432-4. PubMed ID: 20508243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of diazepam on delayed nausea and vomiting caused by anticancer agents].
    Tong FZ; Zhang JQ; Qiao XM; Mao YC; Meng FY; Liu HJ; Hui S; Zhu FX; Shu W; Hong J
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):391-5. PubMed ID: 9492833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
    Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of aprepitant in patients receiving high-dose chemotherapy with hematopoietic stem cell support.
    Paul B; Trovato JA; Thompson J; Badros AZ; Goloubeva O
    J Oncol Pharm Pract; 2010 Mar; 16(1):45-51. PubMed ID: 19525301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. State of the Art Antiemetic Therapy for Cancer Patients.
    Lau TK; Yip CH; Yeo W
    Curr Oncol Rep; 2016 Jan; 18(1):2. PubMed ID: 26694923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent improvements in antiemetic therapy].
    Roila F; Palladino MA; Ciccarese G; Basurto C
    Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
    Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
    Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New developments in the treatment of nausea and vomiting caused by chemotherapy].
    de Wit R; van Alphen MM
    Ned Tijdschr Geneeskd; 2003 Apr; 147(15):690-4. PubMed ID: 12722531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.